Ralf Amann

5PUBLICATIONS
17CO-AUTHORS
Animal protection (incl. pests and pathogens)Innate immunityGene and molecular therapyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 27, 2026
In Vitro Antiviral Properties of Two Recombinant Sendai Virus Vectors Encoding ORFV 011 and ORFV 059 Genes.

|Jan 28, 2026
Broadening SARS-CoV-2 Immunity by Combining ORFV and Protein-Based Vaccines.

Alena Reguzova, Melanie Müller, Madeleine Fandrich

|May 10, 2025
Advancing ORFV-Based Therapeutics to the Clinical Stage.

Matthias Helmold, Ralf Amann

|Nov 26, 2024
First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine Booster.

Meral Esen, Johanna Fischer-Herr, Julian Justin Gabor

Pageof 1

Frequent Collaborators

1 joint publications

Johanna Fischer-Herr

1 joint publications

Sabine Bélard

1 joint publications

Carlos Lamsfus Calle

1 joint publications

Tamirat Gebru Woldearegai